1-3 of 3
Nathalie A Johnson, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax Plus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) Improves Outcomes in BCL2-Positive First-Line Diffuse Large B-Cell Lymphoma (DLBCL): First Safety, Efficacy and Biomarker Analyses from the Phase II CAVALLI Study

Franck Morschhauser, Pierre Feugier, Ian W. Flinn, MD PhD, Robin E Gasiorowski, Richard Greil, MD, Árpád Illés, Nathalie A Johnson, MDPhD, Jean-Francois Larouche, Pieternella J Lugtenburg, Caterina Patti, Gilles Salles, MD PhD, Marek Trněný, Sven de Vos, Farheen Mir, MBBS, Martin Kornacker, Elizabeth A Punnoose, Divya Samineni, Edith Szafer-Glusman, Adam Petrich, Arijit Sinha, Mehrdad Mobasher, MD MPH, Andrew D. Zelenetz, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 782.
https://doi.org/10.1182/blood-2018-99-118519
Published: 2018
Journal Articles

Nivolumab Combined with Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Preliminary Results from the Phase 2 CheckMate 436 Trial

Alison J. Moskowitz, MD, Armando Santoro, MD, Giuseppe Gritti, Pauline Brice, MD, David Cunningham, Paul Barr, MD, Justin Kline, MD, John Kuruvilla, MD, Nathalie A Johnson, MDPhD, Neha Mehta-Shah, MD, Thomas Manley, MD, Manish Sharma, Stephen Francis, Joseph Cohen, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1691.
https://doi.org/10.1182/blood-2018-99-112069
Published: 2018
Journal Articles

Understanding Apoptotic Blocks in "Double Hit" and Other Non-Hodgkin Lymphomas By BH3 Profiling

Claudia M Wever, PhD, Dominique Geoffrion, BSc, Pierre Sesques, MD, Liliana Stoica, Josee Hebert, MD, Jeremy Ryan, Anthony Letai, MD PhD, Nathalie A Johnson, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1471.
https://doi.org/10.1182/blood.V130.Suppl_1.1471.1471
Published: 2017